JPMorgan Chase & Co. Has $23.67 Million Stake in RadNet, Inc. (NASDAQ:RDNT)

featured-image

JPMorgan Chase & Co. raised its position in RadNet, Inc. (NASDAQ:RDNT – Free Report) by 154.8% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 338,843 shares of the medical research company’s stock after purchasing an additional 205,846 shares during the period. JPMorgan Chase & Co. owned 0.46% [...]

JPMorgan Chase & Co. raised its position in RadNet, Inc. ( NASDAQ:RDNT – Free Report ) by 154.

8% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 338,843 shares of the medical research company’s stock after purchasing an additional 205,846 shares during the period. JPMorgan Chase & Co.



owned 0.46% of RadNet worth $23,665,000 as of its most recent filing with the SEC. A number of other large investors have also recently bought and sold shares of RDNT.

Vanguard Group Inc. increased its stake in shares of RadNet by 1.0% in the 4th quarter.

Vanguard Group Inc. now owns 7,425,218 shares of the medical research company’s stock valued at $518,577,000 after acquiring an additional 71,910 shares in the last quarter. State Street Corp lifted its holdings in shares of RadNet by 1.

3% in the third quarter. State Street Corp now owns 2,446,179 shares of the medical research company’s stock valued at $169,740,000 after purchasing an additional 30,244 shares in the last quarter. Geode Capital Management LLC lifted its stake in RadNet by 0.

8% during the 3rd quarter. Geode Capital Management LLC now owns 1,555,214 shares of the medical research company’s stock valued at $107,936,000 after acquiring an additional 11,613 shares in the last quarter. Principal Financial Group Inc.

boosted its holdings in RadNet by 8.5% during the third quarter. Principal Financial Group Inc.

now owns 1,506,545 shares of the medical research company’s stock worth $104,539,000 after purchasing an additional 118,501 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC increased its position in shares of RadNet by 30.4% during the fourth quarter.

Allspring Global Investments Holdings LLC now owns 1,475,995 shares of the medical research company’s stock valued at $103,532,000 after acquiring an additional 344,146 shares during the last quarter. 77.90% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In A number of analysts recently issued reports on the stock. Jefferies Financial Group decreased their price objective on shares of RadNet from $100.00 to $80.

00 and set a “buy” rating for the company in a report on Wednesday, January 15th. Raymond James upgraded RadNet from an “outperform” rating to a “strong-buy” rating and decreased their price target for the company from $85.00 to $65.

00 in a research report on Wednesday, March 5th. Barclays reduced their target price on RadNet from $74.00 to $60.

00 and set an “overweight” rating for the company in a research report on Monday, March 24th. Truist Financial reissued a “buy” rating and issued a $88.00 price target (down previously from $94.

00) on shares of RadNet in a report on Wednesday, January 22nd. Finally, StockNews.com raised RadNet to a “sell” rating in a report on Wednesday, March 19th.

One equities research analyst has rated the stock with a sell rating, three have issued a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of $73.25.

Insider Activity In other RadNet news, COO Norman R. Hames sold 5,000 shares of the company’s stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $50.

22, for a total transaction of $251,100.00. Following the completion of the sale, the chief operating officer now directly owns 251,959 shares of the company’s stock, valued at approximately $12,653,380.

98. This represents a 1.95 % decrease in their ownership of the stock.

The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website . Also, CEO Cornelis Wesdorp sold 2,000 shares of RadNet stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $52.

58, for a total value of $105,160.00. Following the transaction, the chief executive officer now owns 58,995 shares in the company, valued at $3,101,957.

10. This trade represents a 3.28 % decrease in their ownership of the stock.

The disclosure for this sale can be found here . Insiders sold a total of 38,000 shares of company stock worth $1,926,730 in the last quarter. 5.

12% of the stock is owned by company insiders. RadNet Trading Up 11.9 % NASDAQ:RDNT opened at $53.

59 on Thursday. The company has a fifty day moving average of $54.76 and a 200 day moving average of $65.

91. RadNet, Inc. has a 52 week low of $45.

00 and a 52 week high of $93.65. The firm has a market capitalization of $3.

97 billion, a P/E ratio of -765.46 and a beta of 1.59.

The company has a quick ratio of 2.16, a current ratio of 2.16 and a debt-to-equity ratio of 0.

89. RadNet ( NASDAQ:RDNT – Get Free Report ) last posted its earnings results on Thursday, February 27th. The medical research company reported $0.

22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.21 by $0.01.

The firm had revenue of $477.10 million for the quarter, compared to analysts’ expectations of $459.42 million.

RadNet had a positive return on equity of 4.29% and a negative net margin of 0.25%.

On average, research analysts predict that RadNet, Inc. will post 0.56 earnings per share for the current year.

RadNet Company Profile ( Free Report ) RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.

See Also Five stocks we like better than RadNet Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance Quantum Computing: The $6.5 Billion Opportunity You Can’t Ignore 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion Are Tariffs Threatening Disney’s Comeback Story? Options Trading – Understanding Strike Price Is Alphabet a Generational Buying Opportunity at These Levels? Want to see what other hedge funds are holding RDNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for RadNet, Inc.

( NASDAQ:RDNT – Free Report ). Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter .

.